Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3875026 | The Journal of Urology | 2006 | 4 Pages |
Abstract
In most cases biochemical prostate specific antigen recurrence is the initial indicator of treatment failure and eventual progression but prostate specific antigen recurrence alone does not predict clinically significant events. As with determining the risk likelihood, pathological data and prostate specific antigen kinetic characteristics can help predict patient survival.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Sam S. Chang,